NYSE •
Healthcare •
Medical Devices •
Quote as of 06/17/2026 16:00
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNYSE
Market Capitalization7,490.34 mln
Float57.71 mln
Earnings Date08/05/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-2.91
Likely reliable
1-Year Forecast
156
Attractive
Relative Strength
96
/ 100
Top performer
Debt / Equity
0.15
Very low leverage
ROE
-26.11
Deeply negative
Business Description
Glaukos Corporation is a medical technology and eye care company based in Aliso Viejo, California, that develops treatments for glaucoma, corneal conditions, and retinal diseases across the United States and global markets. The company offers a range of products including tiny implants that help fluid drain from the eye to lower pressure in glaucoma patients, a drug-releasing device placed inside the eye, and a treatment for a condition that causes the cornea to thin and bulge. Glaukos also works on a skin-applied eyelid cream that delivers medication without eye drops, as well as therapies targeting serious retinal diseases such as age-related macular degeneration. Its products are sold to surgery centers, hospitals, and private eye care practices through both direct sales teams and distribution partners.